Tengen's
founders and key employees have already developed several proprietary
products from original research, and have developed improved methods
for manufacturing pharmacologic grade substances currently used in certain
OTC drugs or health food items. By combining advanced biomedical technology
with lower cost R & D facilities, procedures and research scientists
in China, Tengen is able to develop and patent drugs, vaccines and other
substances more quickly and at lower cost.
Tengen has several products for which patents have been applied for
in the P.R. China. Products in develpment target the following areas:
Cancer of the liver, cervix, head and neck; Liver disease such as hepatitis
and liver fibrosis; Infectious diseases such as infection of HPV, West
Nile Virus and coronavirus.
